Polysaccharide-based biomaterials with on-demand nitric oxide releasing property regulated by enzyme catalysis

Biomaterials

Volumn 34, Issue 33, 2013, Pages 8450-8458

  Zhao, Qiang ^a   Zhang, Jimin ^b   Song, Lijie ^a   Ji, Qing ^a   Yao, Yao ^a   Cui, Yun ^a   Shen, Jie ^a   Wang, Peng George ^a   Kong, Deling ^a,b  

^a NANKAI UNIVERSITY   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

Author keywords

galactosidase; Cardiovascular biomaterials; Chitosan; Controlled release; Nitric oxide

Indexed keywords

ACTIVATED PARTIAL THROMBOPLASTIN TIME; CARDIOVASCULAR BIOMATERIALS; CONTROLLED RELEASE; DECOMPOSITION PROCESS; GALACTOSIDASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INJECTABLE HYDROGELS; VASCULAR SMOOTH MUSCLE CELLS;

BIOLOGICAL MATERIALS; BIOMATERIALS; CHITOSAN; NITRIC OXIDE;

FUNCTIONAL POLYMERS;

BIOMATERIAL; CHITOSAN; GALACTOSE; GLYCOSIDASE; NITRIC OXIDE; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DECOMPOSITION; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE RICH PLASMA; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS;

CARDIOVASCULAR BIOMATERIALS; CHITOSAN; CONTROLLED RELEASE; NITRIC OXIDE; Β-GALACTOSIDASE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; CLICK CHEMISTRY; DIABETES MELLITUS, TYPE 1; HUMANS; MICE; NITRIC OXIDE; PLATELET ADHESIVENESS; POLYSACCHARIDES;

EID: 84881661063     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.045     Document Type: Article

References (33)

1. Zheng W.T., Wang Z.H., Song L.J., Zhao Q., Zhang J., Li D., et al. Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials 2012, 33:2880-2891.
2. Zilla P., Bezuidenhout D., Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007, 28:5009-5027.
3. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. JR Soc Interface 2011, 8:153-170.
4. SoRelle R. Nobel prize awarded to scientists for nitric oxide discoveries. Circulation 1998, 98:2365-2366.
5. Liu V.W.T., Huang P. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 2008, 77:19-29.
6. Annich G.M., Meinhardt J.P., Mowery K.A., Ashton B.A., Merz S.I., Hirschl R.B., et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 2000, 28:915-920.
7. Batchelor M.M., Reoma S.L., Fleser P.S., Nuthakki V.K., Callahan R.E., Shanley C.J., et al. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. JMed Chem 2003, 46:5153-5161.
8. Fleser P.S., Nuthakki V.K., Malinzak L.E., Callahan R.E., Seymour M.L., Reynolds M.M., et al. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. JVasc Surg 2004, 40:803-811.
9. Zhou Z., Annich G.M., Wu Y., Meyerhoff M.E. Water-soluble poly(ethylenimine)-based nitric oxide donors: preparation, characterization, and potential application in hemodialysis. Biomacromolecules 2006, 7:2565-2574.
10. Miller M.R., Megson I.L. Recent developments in nitric oxide donor drugs. Br J Pharmacol 2007, 151:305-321.
11. Jen M.C., Serrano M.C., van Lith R., Ameer G.A. Polymer-based nitric oxide therapies: recent insights for biomedical applications. Adv Funct Mater 2012, 22:239-260.
12. Mowery K.A., Schoenfisch M.H., Saavedra J.E., Keefer L.K., Meyerhoff M.E. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000, 21:9-21.
13. Zhang L., Wang K., Zhao Q., Zheng W.T., Wang Z.H., Wang S.F., et al. Core-shell fibrous vascular graft with nitric oxide releasing property. Sci China Ser B: Chem 2010, 53:528-534.
14. Wu X., Tang X., Xian M., Wang P.G. Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donors. Tetrahedron Lett 2001, 42:3779-3782.
15. Lallana E., Fernandez-Megia E., Riguera R. Surpassing the use of copper in the click functionalization of polymeric nanostructures: a strain-promoted approach. JAm Chem Soc 2009, 131:5748-5750.
16. Millotti G., Samberger C., Frohlich E., Bernkop-Schnurch A. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility. Biomacromolecules 2009, 10:3023-3027.
17. Bao H., Li L., Gan L.H., Ping Y., Li J., Ravi P. Thermo- and pH-responsive association behavior of dual hydrophilic graft chitosan terpolymer synthesized via ATRP and click chemistry. Macromolecules 2010, 43:5679-5687.
18. Binder W.H., Sachsenhofer R. 'Click' chemistry in polymer and materials science. Macromol Rapid Commun 2007, 28:15-54.
19. Duan S., Cai S., Yang Q., Forrest M.L. Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. Biomaterials 2012, 33:3243-3253.
20. Jonassen H., Kjøniksen A.L., Hiorth M. Stability of chitosan nanoparticles cross-linked with tripolyphosphate. Biomacromolecules 2012, 13:3747-3756.
21. Taite L.J., West J.L. Sustained delivery of nitric oxide from poly(ethylene glycol) hydrogels enhances endothelialization in a rat carotid balloon injury model. Cardiovasc Eng Technol 2011, 2:113-123.
22. 2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents. Biomaterials 2011, 32:1253-1263.
23. Meng S., Liu Z., Shen L., Guo Z., Chou L.L., Zhong W., et al. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009, 30:2276-2283.
24. Bohl K.S., West J.L. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials 2000, 21:2273-2278.
25. Kushwaha M., Anderson J.M., Bosworth C.A., Andukuri A., Minor W.P., Lancaster J.R., et al. Anitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials 2010, 31:1502-1508.
26. Zheng J., Wen Y.X., Austin J.L., Chen D.B. Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biol Reprod 2006, 74:375-382.
27. Jeremy J.Y., Rowe D., Emsley A.M., Newby A.C. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 1999, 43:580-594.
28. Silva E.A., Kim E.S., Kong H.J., Mooney D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. PNAS 2008, 105:14347-14352.
29. Silva E.A., Mooney D.J. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. JThromb Haemost 2007, 5:590-598.
30. Yan J., Tie G., Yang Y., Nowicki P.T., Messina L.M. Recovery from hindlimb ischemia is less effective in type 2 than type 1 diabetic mice: roles of eNOS and endothelial progenitor cells. JVasc Surg 2009, 50:1412-1422.
31. 2-protected diazeniumdiolated chain extenders. JMater Chem 2010, 20:3107-3114.
32. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9:1370-1376.
33. Park B., Hoffman A., Yang Y., Yan J., Tie G., Bagshahi H., et al. eNOS affects both early and late collateral arterial adaptation and blood flow recovery after induction of hindlimb ischemia in mice. JVasc Surg 2010, 51:165-173.